| Type | Description |
|---|---|
| Definition | engrailed homeobox 2 |
| Date | Results | Publications |
|---|---|---|
| 2021-03-27 14:45:00 | EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer. | 32732864 |
| 2021-01-16 15:55:00 | Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate Cancer predict prostatic disease progression. | 32539763 |
| 2020-10-03 12:51:00 | Membrane insertion and secretion of the Engrailed-2 (EN2) transcription factor by prostate cancer cells may induce antiviral activity in the stroma. | 30914795 |
| 2020-06-06 10:04:00 | Urine Engrailed-2 (EN2) has no value as prostate cancer prognostic biomarker. | 31692391 |
| 2018-12-22 11:22:00 | The EN2 transcription factor is a novel ovarian cancer biomarker. It demonstrates prognostic value, correlating with worse Overall Survival and Progression-free Survival. | 30285763 |
| Type | IDs |
|---|---|
| Gene |
UniProtKB-ID:
HME2_HUMAN
UniprotKB:
P19622
UniParc:
UPI000012CA05
EMBL:
BC104972,
AC008060,
L12700,
J03066,
BC104970,
L12701,
CH236954
Ensembl:
ENSG00000164778
KO:
hsa:2020
|
| Nucleutide sequences |
EMBL-CDS:
AAI04971.1,
AAF68670.1,
EAL23909.1,
AAA53504.2,
AAQ96875.1,
AAI04973.1
Ensembl_TRS:
ENST00000297375
|
| Protein sequencees |
Ensembl_PRO:
ENSP00000297375
RefSeq:
NP_001418.2
|
| Others |
UniRef100:
UniRef100_P19622
UniRef90:
UniRef90_P19622
UniRef50:
UniRef50_P09066
UniGene:
Hs.134989
CCDS:
CCDS5940.1
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员